Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1581-1584

  Hibi, Kenji ^a   Sakata, Makiko ^a   Sakuraba, Kazuma ^a   Shirahata, Atsushi ^a   Goto, Tetsuhiro ^a   Mizukami, Hiroki ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Colorectal cancer; HACE1; Quantitative methylation specific PCR

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE; HACE1 GENE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; UBIQUITIN-PROTEIN LIGASES;

EID: 45949100031     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297,1987.
2. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preesinger AC, Smith KJ, Su LK, Kinzler KW and Vogelsteen B: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991.
3. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
4. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482,1996.
5. Hibi K, Taguchi M, Nakamura H, Hirai A, Fujikake Y, Matsui T, Kasai Y, Akiyama S, Ito K and Takagi H: Alternative splicing of the FHIT gene in colorectal cancer. Jpn J Cancer Res 88: 385-388, 1997.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
7. Hyytinen ER, Saadut R, Chen C, Paull L, Koivisto PA, Vessella RL, Frierson HF Jr and Dong JT: Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer 34: 306-312, 2002.
8. Inoue M, Marx A, Zettl A, Ströbel P, Müller-Hermelink HK and Starostik P: Chromosome 6 suffers frequent and multiple aberrations in thymoma. Am J Pathol 161: 1507-1513, 2002.
9. Orphanos V, McGown G, Hey Y, Thorncroft M, Santibanez-Koref M, Russell SE, Hickey I, Atkinson RJ and Boyle JM: Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer 71: 666-669, 1995.
10. Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y and Emi M: Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3. Jpn J Cancer Res 91: 293-300, 2000.
11. Zhang Y, Matthiesen P, Harder S, Siebert R, Castoldi G, Calasanz MJ, Wong KF, Rosenwald A, Ott G, Atkin NB and Schlegelberger B: A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 27: 52-58, 2000.
12. Zhang L, Anglesio MS, O'Sullivan M, Zhang F, Yang G, Sarao R, Mai PN, Cronin S, Hara H, Melnyk N, Li L, Wada T, Liu PP, Farrar J, Arceci RJ, Sorensen PH and Penninger JM: The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat Med 13: 1060-1069, 2007.
13. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138, 2001.
14. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
15. Hibi K, Nakayama H, Koike M, Kasai Y, Ito K, Akiyama S and Nakao A: Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn J Cancer Res 93: 883-887, 2002.
16. Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S and Nakao A: CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 90: 1030-1033, 2004.
17. Hibi K and Nakao A: Highly-methylated colorectal cancers show poorly-differentiated phenotype. Anticancer Res 26: 4263-4266, 2006.